Headache Symptoms Broadened for State’s Medical Marijuana Patients

By
Maureen Meehan

Connecticut’s medical marijuana program has over 19,000 certified patients in this state of 3.5 million people—and that number will likely grow, a lot.

The board of physicians that supervises the inclusion of new ailments deemed eligible to use MMJ is redefining the list of headache-related ailments with an umbrella term to cover all intractable headache syndromes.

The current list specified only migraines and trigeminal neuralgia sufferers.

This new classification will give doctors more latitude for certifying new patients to use medical cannabis as a headache treatment.

The board of physicians also approved neuropathic face pain for inclusion in the five-year-old medical marijuana program, in which there are 724 medical professionals registered, according to the CTPost.

Michelle Seagull, commissioner of the state Department of Consumer Protection, which administers the MMJ program, approved the two conditions.

“A lot of these conditions have the same sorts of effects on people, even though it may be another condition that leads to that,” Seagull said. “It may make sense rather than doing it disease state by disease state, and to look at it more, kind of, holistically. The theory was that maybe we should look at conditions more broadly.”

A physician on the board, Dr. Andrew L. Salner, agreed: “I think the sense was, there are innumerable headache syndromes with intractable pain and rather discussing and ultimately qualifying every one, which could potentially be 20, the question was whether we could come up with a term that would be more inclusive for patients who suffer from these severe syndromes, so we could provide access to the program.”

A recent study showed a reduction in the severity and length of headaches among patients using cannabis.

“I think we’re going to see that continue, especially with neurological types of pain conditions,” said Dr. Jonathan A. Kost, an anesthesiologist in West Hartford, Connecticut.

In view of the rush to prescribe opioids and other prescription drugs, which currently has millions of Americans addicted, dying from overdoses or incarcerated, isn’t it time to start looking at safe alternatives?

Maureen Meehan

Maureen Meehan is a New York-based writer, who has worked as a foreign correspondent for many years.

By
Maureen Meehan

Recent Posts

Cannabis Community, Investors React to DEA Decision To Reschedule

Cannabis advocates hailed the DEA’s decision to reclassify marijuana under federal drugs laws, although many…

24 hours ago

Ohio GOP Lawmakers Debate Adult-Use MJ Priorities, Eye June for Regulation Approval

Ohio's recreational market remains in limbo, for now.

24 hours ago

Georgia Governor Signs Bill Establishing Licensing Requirements To Grow Hemp

The governor of Georgia signed a series of bills aimed at bolstering the state’s agriculture…

24 hours ago

Study: Psilocybin Enhances Meditation

For those seeking enlightenment through meditation, psilocybin might do the trick.

24 hours ago

Taylor Swift Puts Narcotics Into All of Her Songs on ‘The Tortured Poets Department’

On her latest album, the megastar is more open about substance abuse than ever before.

24 hours ago

MedMen Files for Bankruptcy

The once prominent cannabis company has now entered receivership, and its assets and operations will…

2 days ago